Long-Term Follow-Up in Patients With Acute Myocardial Infarction Cohort
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorYu Bo
About this trial
AMI Survivors who participated in the project "Construction and key technology research of the whole myocardial protection system for acute myocardial infarction" (project number 2016YFC1301100) and completed the 1-year visit were followed up by telephone at 3 years (within the corresponding follow-up time window) and 5 years after discharge to acquire the patients' medication, health status, and major adverse cardiovascular and cerebrovascular events, including death, heart failure, rehospitalization, re-myocardial infarction, revascularization, stroke, malignant arrhythmia, and bleeding events.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
AMI survivors who participated in the project "Construction and key technology research of the whole myocardial protection system for acute myocardial infarction" and completed the 1-year visit.
Telephone to obtain informed consent from the subjects/family members of the subjects.
Disqualifiers
Not available
Trial population
AMI survivors who participated in the project "Construction and key technology research on the whole myocardial protection system for acute myocardial infarction" and completed 1-year visit
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
Treatment Strategies
Other interventionAMI emergency treatment process, pre-reperfusion medication, reperfusion strategy selection, and early cardiac rehabilitation after reperfusion
Treatment groups
15,000 Participants
are divided into 2 treatment groupsGroup A: optimized group1 intervention
Group B: un-optimized group0 interventions
Trial outcomes
Primary outcomes
1
Incidence of MACCE
the incidence of MACCE (death, heart failure, rehospitalization, re-myocardial infarction, re-myocardial revascularization, stroke, malignant arrhythmia, bleeding events, etc.) in AMI patients
Time frame
5 years after dischargeSecondary outcomes
1
Differences of MACCE between the optimized group and the non-optimized group
Differences of the MACCE between the optimized group and the non-optimized group
Time frame
5 years after discharge2
Differences of the MACCE between OCT-guided group and the coronary angiography -guided group
Differences of the MACCE between OCT-guided group and the coronary angiography -guided group
Time frame
5 years after discharge3
Differences of MACCE between defer PCI group and direct PCI group
Differences of MACCE between defer PCI group and direct PCI group
Time frame
3 and 5 years after discharge4
Differences of the MACCE incidence between cardiac rehabilitation quality improvement group and non-cardiac rehabilitation group
Differences of the MACCE incidence between cardiac rehabilitation quality improvement group and non-cardiac rehabilitation group
Time frame
5 years after dischargeSponsors and contacts
Click on the lead sponsor to view all of their trials.
Yu Bo
Lead sponsor
Harbin Medical University
Sponsor institution
Source ClinicalTrials.gov